Peter Hjelmström

3.0k total citations
46 papers, 2.4k citations indexed

About

Peter Hjelmström is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Neurology. According to data from OpenAlex, Peter Hjelmström has authored 46 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 13 papers in Public Health, Environmental and Occupational Health and 9 papers in Neurology. Recurrent topics in Peter Hjelmström's work include Opioid Use Disorder Treatment (13 papers), Immunotherapy and Immune Responses (9 papers) and Pain Management and Opioid Use (8 papers). Peter Hjelmström is often cited by papers focused on Opioid Use Disorder Treatment (13 papers), Immunotherapy and Immune Responses (9 papers) and Pain Management and Opioid Use (8 papers). Peter Hjelmström collaborates with scholars based in Sweden, United States and China. Peter Hjelmström's co-authors include Nancy H. Ruddle, Jenny Fjell, Amy E. Juedes, Marie Wahren‐Herlenius, Stina Salomonsson, Cheryl M. Bergman, Roland Jonsson, Karl A. Brokstad, Kathrine Skarstein and Malin V. Jonsson and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

Peter Hjelmström

45 papers receiving 2.4k citations

Peers

Countries citing papers authored by Peter Hjelmström

Since Specialization

Citations

This map shows the geographic impact of Peter Hjelmström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hjelmström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hjelmström more than expected).

Fields of papers citing papers by Peter Hjelmström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hjelmström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hjelmström. The network helps show where Peter Hjelmström may publish in the future.

Co-authorship network of co-authors of Peter Hjelmström

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hjelmström. A scholar is included among the top collaborators of Peter Hjelmström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hjelmström. Peter Hjelmström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	VigiBase: Resource Profile Update with a Summary of Global Patterns and Trends in Adverse Event Reports for Medicines and Vaccines 2026 ·Drug Safety ·(unknown), (unknown), Daniele Sartori, Michele Fusaroli, (unknown), (unknown), (unknown), (unknown), Peter Hjelmström, (unknown)	0
2	Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder 2024 ·Neuropsychopharmacology ·Sharon Walsh, Sandra D. Comer, (unknown), Céline Sarr, (unknown), (unknown), Peter Hjelmström, Fredrik Tiberg	3
3	Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone 2021 ·Drug and Alcohol Dependence ·Benjamin Rolland, Benoît Trojak, Mikaïl Nourredine, (unknown), (unknown), (unknown), (unknown), Peter Hjelmström, (unknown), Philippe Nubukpo, Georges Brousse	14
4	Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder 2021 ·Patient Preference and Adherence ·(unknown), (unknown), Benoît Trojak, (unknown), (unknown), (unknown), Peter Hjelmström, Philippe Nubukpo, Georges Brousse, Benjamin Rolland	9
5	Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data 2020 ·Drug Development and Industrial Pharmacy ·Peter Hjelmström, (unknown), Fredrik Tiberg	29
6	Methadone‐related deaths among youth and young adults in Sweden 2006–15 2020 ·Addiction ·Anna Fugelstad, Sven Bremberg, Peter Hjelmström, Ingemar Thiblin	9
7	Effects of a Higher-bioavailability Buprenorphine/Naloxone Sublingual Tablet Versus Buprenorphine/Naloxone Film for the Treatment of Opioid Dependence During Induction and Stabilization: A Multicenter, Randomized Trial 2015 ·Clinical Therapeutics ·Erik W. Gunderson, Peter Hjelmström, Michael Sumner	16
8	Enhanced plasma levels of LIGHT in patients with acute atherothrombotic stroke 2008 ·Acta Neurologica Scandinavica ·(unknown), (unknown), Peter Hjelmström, (unknown)	8
9	Increased Soluble 4‐1BB Ligand (4‐1BBL) Levels in Peripheral Blood of Patients with Multiple Sclerosis 2006 ·Scandinavian Journal of Immunology ·(unknown), Andreia C. Gomes, Prabhakar Putheti, Virginija Danylaité Karrenbauer, (unknown), Rayomand Press, Jan Hillert, Peter Hjelmström, (unknown)	17
10	Increased central memory T cells in patients with chronic pancreatitis 2005 ·Pancreatology ·(unknown), (unknown), Johan Permert, Peter Hjelmström, Jon A. Tsai	24
11	Lack of association of human chemokine receptor gene polymorphisms CCR2‐64I and CCR5‐Δ32 with autoimmune Addison's disease 2004 ·European Journal of Immunogenetics ·Giovanni Gambelunghe, Mehran Ghaderi, Baback Gharizadeh, Annalisa Brozzetti, (unknown), Paola Sindaco, Carani B. Sanjeevi, Peter Hjelmström, Allan Sirsjö, P. Nyrén, Fausto Santeusanio, A Falorni	7
12	Lack of association of CCR2–64I and CCR5-Δ32 with type 1 diabetes and latent autoimmune diabetes in adults 2003 ·Human Immunology ·Giovanni Gambelunghe, Mehran Ghaderi, Annalisa Brozzetti, Paola Sindaco, (unknown), P. Nyrén, Peter Hjelmström, Liene Ņikitina-Zaķe, Carani B. Sanjeevi, Alberto Falorni	13
13	Expression of the B Cell‐Attracting Chemokine CXCL13 in the Target Organ and Autoantibody Production in Ectopic Lymphoid Tissue in the Chronic Inflammatory Disease Sjögren's Syndrome 2002 ·Scandinavian Journal of Immunology ·Stina Salomonsson, Per Larsson, (unknown), (unknown), Peter Hjelmström, Marie Wahren‐Herlenius	143
14	Localization of the tetrodotoxin-resistant sodium channel NaN in nociceptors 2000 ·Neuroreport ·Jenny Fjell, Peter Hjelmström, W. N. Hormuzdiar, Milan Milenković, Fabio Aglieco, Lynda Tyrrell, Sulayman D. Dib‐Hajj, Stephen G. Waxman, Joel A. Black	100
15	MICA gene polymorphism and the risk to develop cervical intraepithelial neoplasia 1999 ·Human Immunology ·Mehran Ghaderi, Peter Hjelmström, G. Hallmans, Fredrik Wiklund, (unknown), Joakim Dillner, Carani B. Sanjeevi	22
16	Myasthenia Gravis with Thymic Hyperplasia Is Associated with Polymorphisms in the Tumor Necrosis Factor Region 1998 ·Annals of the New York Academy of Sciences ·Peter Hjelmström, Christopher S. Peacock, Ricardo Giscombe, Ritva Pirskanen, Ann Kari Lefvert, Jenefer M. Blackwell, Carani B. Sanjeevi	6
17	Polymorphism in tumor necrosis factor genes associated with myasthenia gravis 1998 ·Journal of Neuroimmunology ·Peter Hjelmström, Christopher S. Peacock, Ricardo Giscombe, Ritva Pirskanen, Ann Kari Lefvert, Jenefer M. Blackwell, Carani B. Sanjeevi	23
18	A Molecular Model of Myelin Oligodendrocyte Glycoprotein 1998 ·Journal of Neurochemistry ·Peter Hjelmström, Julie E. Penzotti, (unknown), Terry P. Lybrand	13
19	Structural differences between HLA-DQ molecules associated with myasthenia gravis characterized by molecular modeling 1998 ·Journal of Neuroimmunology ·Peter Hjelmström, (unknown), Julie E. Penzotti, Terry P. Lybrand, Carani B. Sanjeevi	10
20	Different HLA-DQ are Positively and Negatively Associated in Swedish Patients with Myasthenia Gravis 1995 ·Autoimmunity ·Peter Hjelmström, Ricardo Giscombe, Ann Kari Lefvert, Ritva Pirskanen, Ingrid Kockum, Mona Landin‐Olsson, Carani B. Sanjeevi	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact